Evidence map›Paper›PMID 35647888›Full record

ArticleMicrobiology spectrum2022

Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.

Ongeziwe Taku, Harris Onywera, Zizipho Z A Mbulawa, Charles B Businge, Tracy L Meiring, Anna-Lise Williamson

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Interactions between microbiota and cervical epithelial, immune, and mucus barrier.Frontiers in cellular and infection microbiology · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ongeziwe Taku *Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Towngrid.7836.a, Cape Town, South Africa.
Harris Onywera *Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Towngrid.7836.a, Cape Town, South Africa.ORCID 0000-0002-7298-4921
Zizipho Z A MbulawaDivision of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Towngrid.7836.a, Cape Town, South Africa.
Charles B BusingeDepartment of Obstetrics and Gynaecology, Nelson Mandela Academic Hospital, Mthatha, South Africa.
Tracy L MeiringDivision of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Towngrid.7836.a, Cape Town, South Africa.
Anna-Lise WilliamsonDivision of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Towngrid.7836.a, Cape Town, South Africa.
University of Cape Town · ZANational Health Laboratory Service · ZANelson Mandela Academic Hospital · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial vaginosis (BV) is a common polymicrobial vaginal disorder that is associated with sexually transmitted infections (STIs), including HIV. Several studies have utilized broad-range 16S rRNA gene PCR assays with sequence analysis to characterize cervicovaginal bacterial communities of women with healthy and diseased conditions. With the high burden of BV and STIs among African women, there is a need for targeted PCR assays that can rapidly determine the true epidemiological profile of key cervical microbes, including BV-associated bacteria, and a need to explore the utility of such assays for microbiological diagnosis of BV. Here, we used a taxon-directed 16S rRNA gene quantitative PCR (qPCR) assay to examine the prevalences and determinants of specific cervical microbes among African women with and without HIV infection. Cervical samples were collected using a cytobrush from 162 women (aged ≥30 years) attending a community-based clinic in Eastern Cape, South Africa. The samples were screened for specific microbes (i.e., STIs, emerging sexually transmitted pathogens [pathobionts], and BV-associated bacteria) using a customized bacterial vaginosis microbial DNA qPCR array. Statistical analyses were performed using GraphPad Prism v6.01. Chi-square/Fisher's exact tests were used to evaluate the determinants associated with specific cervical microbes. Only 145 women had any detectable microbes and were included in the analysis. Lactobacillus iners (62.8%) and specific BV-associated bacteria, namely, Gardnerella vaginalis (58.6%), Atopobium vaginae (40.7%), and the pathobiont Ureaplasma parvum (37.9%), were the most prevalent microbes. Hierarchical clustering analysis revealed that 42.8% of the women (62/145) had a diverse array of heterogeneously distributed bacteria typically linked to BV. Women with detectable

Indexed as

HIV InfectionsSexually Transmitted DiseasesVaginosis, BacterialAdultAgedChlamydia trachomatisDNAFemaleHumansMiddle AgedPolymerase Chain ReactionRNA, Ribosomal, 16SSouth AfricaVaginaDNARNA, Ribosomal, 16SAfrican womenbacterial vaginosis (BV)bacterial vaginosis microbial DNA qPCR arraycervical microbesemerging sexually transmitted pathogen (pathobiont)HIVsexually transmitted infection (STI)

Identifiers

PMID35647888
PMCPMC9241767
OpenAlexW4281636906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.